Works matching DE "CD38 antigen"
Results: 386
Study of Interaction of the PARP Family DNA-Dependent Proteins with Nucleosomes Containing DNA Intermediates of the Initial Stages of BER Process.
- Published in:
- Biochemistry (00062979), 2022, v. 87, n. 4, p. 331, doi. 10.1134/S0006297922040034
- By:
- Publication type:
- Article
Parental Oxytocin and Early Caregiving Jointly Shape Children's Oxytocin Response and Social Reciprocity.
- Published in:
- Neuropsychopharmacology, 2013, v. 38, n. 7, p. 1154, doi. 10.1038/npp.2013.22
- By:
- Publication type:
- Article
Preclinical Evaluation of a Novel Series of Polyfluorinated Thalidomide Analogs in Drug-Resistant Multiple Myeloma.
- Published in:
- Biomolecules (2218-273X), 2024, v. 14, n. 6, p. 725, doi. 10.3390/biom14060725
- By:
- Publication type:
- Article
The Role of Poly(ADP-ribose) Polymerase 1 in Nuclear and Mitochondrial Base Excision Repair.
- Published in:
- Biomolecules (2218-273X), 2023, v. 13, n. 8, p. 1195, doi. 10.3390/biom13081195
- By:
- Publication type:
- Article
Molecular Determinants Underlying the Anti-Cancer Efficacy of CD38 Monoclonal Antibodies in Hematological Malignancies.
- Published in:
- Biomolecules (2218-273X), 2022, v. 12, n. 9, p. 1261, doi. 10.3390/biom12091261
- By:
- Publication type:
- Article
Adoptive NK Cell Therapy - a Beacon of Hope in Multiple Myeloma Treatment.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1275076
- By:
- Publication type:
- Article
The role of daratumumab in relapsed/refractory CD38 positive acute leukemias—case report on three cases with a literature review.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1228481
- By:
- Publication type:
- Article
The role of daratumumab in relapsed/refractory CD38 positive acute leukemias--case report on three cases with a literature review.
- Published in:
- Frontiers in Oncology, 2023, p. 1, doi. 10.3389/fonc.2023.1228481
- By:
- Publication type:
- Article
Long term follow-up of humoral and cellular response to mRNA-based vaccines for SARS-CoV-2 in patients with active multiple myeloma.
- Published in:
- Frontiers in Oncology, 2023, p. 01, doi. 10.3389/fonc.2023.1208741
- By:
- Publication type:
- Article
CD38 marks the exhausted CD8<sup>+</sup> tissue-resident memory T cells in hepatocellular carcinoma.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1182016
- By:
- Publication type:
- Article
Impact of the flame retardant 2,2'4,4'-tetrabromodiphenyl ether (PBDE-47) in THP-1 macrophage-like cell function via small extracellular vesicles.
- Published in:
- Frontiers in Immunology, 2023, v. 13, p. 01, doi. 10.3389/fimmu.2022.1069207
- By:
- Publication type:
- Article
Remission of social behavior impairment by oral administration of a precursor of NAD in CD157, but not in CD38, knockout mice.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1166609
- By:
- Publication type:
- Article
CD38: an ecto-enzyme with functional diversity in T cells.
- Published in:
- Frontiers in Immunology, 2023, p. 1, doi. 10.3389/fimmu.2023.1146791
- By:
- Publication type:
- Article
The importance of removing interference caused by Darzalex<sup>®</sup> (daratumumab) in pre-transfusion testing.
- Published in:
- 2023
- By:
- Publication type:
- Case Study
Characterization of a d-lyxose isomerase from Bacillus velezensis and its application for the production of d-mannose and l-ribose.
- Published in:
- AMB Express, 2019, v. 9, n. 1, p. N.PAG, doi. 10.1186/s13568-019-0877-3
- By:
- Publication type:
- Article
Biochemical Evidence Indicates the Preventive Effect of Resveratrol and Nicotinamide in the Treatment of STZ-induced Diabetic Cataract.
- Published in:
- Current Eye Research, 2021, v. 46, n. 1, p. 52, doi. 10.1080/02713683.2020.1782941
- By:
- Publication type:
- Article
Common gene variants within 3′‐untranslated regions as modulators of multiple myeloma risk and survival.
- Published in:
- International Journal of Cancer, 2021, v. 148, n. 8, p. 1887, doi. 10.1002/ijc.33377
- By:
- Publication type:
- Article
Excessive serine from the bone marrow microenvironment impairs megakaryopoiesis and thrombopoiesis in Multiple Myeloma.
- Published in:
- Nature Communications, 2023, v. 14, n. 1, p. 1, doi. 10.1038/s41467-023-37699-z
- By:
- Publication type:
- Article
Loss of Heterozygosity in the Circulating Tumor DNA and CD138+ Bone Marrow Cells in Multiple Myeloma.
- Published in:
- Genes, 2023, v. 14, n. 2, p. 351, doi. 10.3390/genes14020351
- By:
- Publication type:
- Article
The PARP Way to Epigenetic Changes.
- Published in:
- Genes, 2021, v. 12, n. 3, p. 446, doi. 10.3390/genes12030446
- By:
- Publication type:
- Article
Small-Molecule Anti-Cancer Drugs From 2016 to 2020: Synthesis and Clinical Application.
- Published in:
- Natural Product Communications, 2021, v. 16, n. 9, p. 1, doi. 10.1177/1934578X211040326
- By:
- Publication type:
- Article
INCIDENCE OF GENETIC MARKERS ASSOCIATED WITH MULTIPLE MYELOMA CHARACTERIZED BY FISH.
- Published in:
- Journal of the Association of Genetic Technologists, 2022, v. 48, n. 3, p. 142
- By:
- Publication type:
- Article
The era of lenalidomide maintenance therapy in multiple myeloma: settings for achieving best outcomes.
- Published in:
- Expert Review of Clinical Pharmacology, 2022, v. 15, n. 1, p. 19, doi. 10.1080/17512433.2022.2032656
- By:
- Publication type:
- Article
Global DNA methylation and increased DNMT3A expression in multiple myeloma patients.
- Published in:
- Biomedical Papers of the Medical Faculty of Palacky University in Olomouc, 2023, v. 167, n. 1, p. 43, doi. 10.5507/bp.2022.006
- By:
- Publication type:
- Article
Flow cytometric immunophenotypic features of acute myeloid leukemia with mast cell differentiation.
- Published in:
- American Journal of Clinical Pathology, 2025, v. 163, n. 2, p. 240, doi. 10.1093/ajcp/aqae116
- By:
- Publication type:
- Article
Integrative immunophenotypic and genetic characterization of acute myeloid leukemia with CBFB rearrangement.
- Published in:
- American Journal of Clinical Pathology, 2024, v. 162, n. 5, p. 455, doi. 10.1093/ajcp/aqae060
- By:
- Publication type:
- Article
Camelid-derived CD38 antibody successfully circumvents epitope blockade by the therapeutic anti-CD38 antibody daratumumab.
- Published in:
- American Journal of Clinical Pathology, 2023, v. 160, n. 5, p. 524, doi. 10.1093/ajcp/aqad086
- By:
- Publication type:
- Article
Current Novel Targeted Therapeutic Strategies in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 11, p. 6192, doi. 10.3390/ijms25116192
- By:
- Publication type:
- Article
Tinostamustine (EDO-S101), an Alkylating Deacetylase Inhibitor, Enhances the Efficacy of Daratumumab in Multiple Myeloma by Upregulation of CD38 and NKG2D Ligands.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 9, p. 4718, doi. 10.3390/ijms25094718
- By:
- Publication type:
- Article
Smooth-Muscle-Cell-Specific Deletion of CD38 Protects Mice from AngII-Induced Abdominal Aortic Aneurysm through Inhibiting Vascular Remodeling.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 8, p. 4356, doi. 10.3390/ijms25084356
- By:
- Publication type:
- Article
Editorial: Multiple Myeloma: Molecular Mechanism and Targeted Therapy.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 7, p. 3799, doi. 10.3390/ijms25073799
- By:
- Publication type:
- Article
Investigating Vα7.2 + /CD161 − T Cell and MAIT Cell Profiles Using Flow Cytometry in Healthy Subjects and Subjects with Atopic Dermatitis.
- Published in:
- International Journal of Molecular Sciences, 2024, v. 25, n. 6, p. 3486, doi. 10.3390/ijms25063486
- By:
- Publication type:
- Article
Nicotinamide-Expanded Allogeneic Natural Killer Cells with CD38 Deletion, Expressing an Enhanced CD38 Chimeric Antigen Receptor, Target Multiple Myeloma Cells.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 24, p. 17231, doi. 10.3390/ijms242417231
- By:
- Publication type:
- Article
Prognostic Impact of CD38- and IgκC-Positive Tumor-Infiltrating Plasma Cells in Triple-Negative Breast Cancer.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 20, p. 15219, doi. 10.3390/ijms242015219
- By:
- Publication type:
- Article
SF3B1 Mutations Are Associated with Resistance to Non-Genotoxic MDM2 Inhibition in Chronic Lymphocytic Leukemia.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 14, p. 11335, doi. 10.3390/ijms241411335
- By:
- Publication type:
- Article
Autophagy: A Potential Therapeutic Target to Tackle Drug Resistance in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2023, v. 24, n. 7, p. 6019, doi. 10.3390/ijms24076019
- By:
- Publication type:
- Article
Newly Synthesized Melphalan Analogs Induce DNA Damage and Mitotic Catastrophe in Hematological Malignant Cancer Cells.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 22, p. 14258, doi. 10.3390/ijms232214258
- By:
- Publication type:
- Article
Pericentromeric Non-Coding DNA Transcription Is Associated with Niche Impairment in Patients with Ineffective or Partially Effective Multiple Myeloma Treatment.
- Published in:
- International Journal of Molecular Sciences, 2022, v. 23, n. 6, p. 3359, doi. 10.3390/ijms23063359
- By:
- Publication type:
- Article
CD38 Correlates with an Immunosuppressive Treg Phenotype in Lupus-Prone Mice.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11977, doi. 10.3390/ijms222111977
- By:
- Publication type:
- Article
Oleil Hydroxytyrosol (HTOL) Exerts Anti-Myeloma Activity by Antagonizing Key Survival Pathways in Malignant Plasma Cells.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 21, p. 11639, doi. 10.3390/ijms222111639
- By:
- Publication type:
- Article
Synergistic Effects of Venetoclax and Daratumumab on Antibody-Dependent Cell-Mediated Natural Killer Cytotoxicity in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 19, p. 10761, doi. 10.3390/ijms221910761
- By:
- Publication type:
- Article
Intermittent Hypoxia Upregulates the Renin and Cd38 mRNAs in Renin-Producing Cells via the Downregulation of miR-203.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 18, p. 10127, doi. 10.3390/ijms221810127
- By:
- Publication type:
- Article
HDAC6-Selective Inhibitor Overcomes Bortezomib Resistance in Multiple Myeloma.
- Published in:
- International Journal of Molecular Sciences, 2021, v. 22, n. 3, p. 1341, doi. 10.3390/ijms22031341
- By:
- Publication type:
- Article
Downregulation of miR-140-3p Contributes to Upregulation of CD38 Protein in Bronchial Smooth Muscle Cells.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 21, p. 7982, doi. 10.3390/ijms21217982
- By:
- Publication type:
- Article
Fused in Sarcoma (FUS) in DNA Repair: Tango with Poly(ADP-ribose) Polymerase 1 and Compartmentalisation of Damaged DNA.
- Published in:
- International Journal of Molecular Sciences, 2020, v. 21, n. 19, p. 7020, doi. 10.3390/ijms21197020
- By:
- Publication type:
- Article
The Role of CD38 on the Function of Regulatory B Cells in a Murine Model of Lupus.
- Published in:
- International Journal of Molecular Sciences, 2018, v. 19, n. 10, p. 2906, doi. 10.3390/ijms19102906
- By:
- Publication type:
- Article
New perspectives on the plant PARP family: Arabidopsis PARP3 is inactive, and PARP1 exhibits predominant poly (ADP-ribose) polymerase activity in response to DNA damage.
- Published in:
- BMC Plant Biology, 2019, v. 19, n. 1, p. N.PAG, doi. 10.1186/s12870-019-1958-9
- By:
- Publication type:
- Article
HIV-1 infection depletes human CD34<sup>+</sup>CD38<sup>-</sup> hematopoietic progenitor cells via pDC-dependent mechanisms.
- Published in:
- PLoS Pathogens, 2017, v. 13, n. 7, p. 1, doi. 10.1371/journal.ppat.1006505
- By:
- Publication type:
- Article
Interleukin-32γ promotes macrophage-mediated chemoresistance by inducing CSF1-dependent M2 macrophage polarization in multiple myeloma.
- Published in:
- Cancer Immunology, Immunotherapy, 2023, v. 72, n. 2, p. 327, doi. 10.1007/s00262-022-03241-1
- By:
- Publication type:
- Article
Daratumumab augments alloreactive natural killer cell cytotoxicity towards CD38+ multiple myeloma cell lines in a biochemical context mimicking tumour microenvironment conditions.
- Published in:
- Cancer Immunology, Immunotherapy, 2018, v. 67, n. 6, p. 861, doi. 10.1007/s00262-018-2140-1
- By:
- Publication type:
- Article